SYK · Business segments
Stryker (SYK) revenue by segment
Where Stryker’s revenue comes from, as reported in its SEC filings.
Latest quarter: September 30, 2026
Total revenue on the income statement: $6.52B.
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| MedSurg and Neurotechnology | $3.66B | 56.2% | $1.05B | 28.7% |
| Orthopaedics and Spine | $2.86B | 43.8% | — | — |
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $4.95B | 75.9% |
| Non-US | $1.57B | 24.1% |
Latest year: December 31, 2025
Total revenue on the income statement: $25.12B.
Revenue by Geography
| Line | Revenue | Share |
|---|---|---|
| United States | $19.01B | 75.7% |
| EMEA | $3.18B | 12.7% |
| Asia Pacific | $2.16B | 8.6% |
| Other Foreign Countries | $765M | 3.0% |
Revenue by Segment
| Line | Revenue | Share | Operating income | Margin |
|---|---|---|---|---|
| MedSurg and Neurotechnology | $15.65B | 62.3% | $4.67B | 29.9% |
| Orthopaedics and Spine | $9.47B | 37.7% | — | — |
Reading notes
Share is each line’s part of that breakdown. Margin is the company’s reported segment operating income divided by that segment’s revenue. Companies define segment profit differently and may re-cut segments over time, so a company’s lines can differ between years. Breakdowns that do not add up to within 5% of reported revenue are left out.